Skip to main content

Table 3 Adjusted ORs (95% CI) for the associations between apoB/apoA1 ratio and risk of MetS

From: The value of Apolipoprotein B/Apolipoprotein A1 ratio for metabolic syndrome diagnosis in a Chinese population: a cross-sectional study

 

Quartiles of apoB/apoA1 ratio

 

Models

Q1 (<0.61)

Q2 (0.61-0.78)

Q3 (0.78-0.98)

Q4 (≥0.98)

P trend

All subjects

     

   Model 1a

Reference

1.40 (1.11-1.76)

2.57 (2.07-3.19)

4.30 (3.48-5.32)

<0.0001

   Model 2b

Reference

1.37 (1.08-1.73)

2.59 (2.08-3.23)

4.28 (3.44-5.31)

<0.0001

   Model 3c

Reference

1.35 (1.06-1.73)

2.69 (2.13-3.89)

4.24 (3.37-5.32)

<0.0001

Men

     

   Model 1a

Reference

1.04 (0.69-1.57)

1.96 (1.36-2.84)

2.92 (2.05-4.16)

<0.0001

   Model 2b

Reference

0.98 (0.64-1.48)

1.97 (1.36-2.87)

2.89 (2.01-4.13)

<0.0001

   Model 3c

Reference

0.94 (0.61-1.45)

1.93 (1.31-2.85)

2.64 (1.82-3.83)

<0.0001

Women

     

   Model 1a

Reference

1.58 (1.19-2.09)

2.74 (2.10-3.58)

4.95 (3.78-6.47)

<0.0001

   Model 2b

Reference

1.58 (1.19-2.11)

2.79 (2.12-3.66)

4.93 (3.75-6.48)

<0.0001

   Model 3c

Reference

1.58 (1.17-2.14)

2.99 (2.24-4.00)

5.18 (3.87-6.92)

<0.0001

  1. aModel 1 was adjusted by age, gender and BMI.
  2. bbased on Model 1, Model 2 was additionally adjusted by smoking, drinking, urbanization index, educational levels, dietary energy intake everyday, gross household income per year.
  3. cbased on Model 2, Model 3 was additionally adjusted by history of CVD, hypertension, diabetes.